Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative IV Iron in Colorectal Cancer Anemia
NCT05221957Unknown
- Sponsor
- Zealand University Hospital
- Start
- Mar 2022
- Primary completion
- Dec 2023
- Modality
- Inorganic Nanoparticles, Small Molecules
01
Overview
Open-label trial of ferric derisomaltose in iron deficiency anemia (IDA) (3 arms), sponsored by Zealand University Hospital. Primary endpoints: Gene expression and lymphocyte infiltration of the tumor and Complications. Status: unknown.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05221957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05221957.